Search Results 851-860 of 17751 for corticosteroid

1. Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab - Mayo Clinic

   ... corticosteroid (OCS) dose \<=7.5 mg/day of prednisolone or equivalent ... Receipt of intravenous/intramuscular/subcutaneous corticosteroids within 4 ...

2. Study of Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis - Mayo Clinic

   mycophenolate mofetil, tacrolimus, oral corticosteroids (OCS) >20 mg/day or the combination of OCS+AZA+N-acetylcysteine within 30 days prior to Baseline ...

3. Safety and Immune Response of the COVID 19 Vaccine in Patients with Inflammatory Bowel Disease - Mayo Clinic

   current use of systemic corticosteroids. Exclusion Criteria: Previously received COVID 19 vaccine. Participating Mayo Clinic locations. Study statuses change ...

4. Ixazomib Citrate, Lenalidomide, Dexamethasone, and Daratumumab in Treating Patients With Newly Diagnosed Multiple Myeloma - Mayo Clinic

   Known allergies, hypersensitivity, or intolerance to corticosteroids, monoclonal antibodies or human proteins, or their excipients (refer to respective ...

5. Publications - Chris R. Carpenter, M.D. - Mayo Clinic

   Corticosteroids for patients with vestibular neuritis: An evidence synthesis for guidelines for reasonable and appropriate care in the emergency department.

6. Glucosamine - Mayo Clinic

   Osteoarthritis. Oral use of glucosamine sulfate might provide some pain relief for people with osteoarthritis of the knee. · Rheumatoid arthritis. Early research ...

7. Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS - Mayo Clinic

   ... corticosteroids (any dose) may continue therapy up until the new regimen has started at investigator discretion; corticosteroids can be tapered to lowest ...

8. SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Chronic Myelomonocytic Leukemia) - Mayo Clinic

   Patient is receiving immunosuppressive therapy, with the exception of corticosteroids ... Patient requires corticosteroid therapy at a dose of >20 mg daily >7 ...

9. A Study of Platelet Rich Plasma for the Treatment of Degenerative Joint Disease of the Lumbar Spine - Mayo Clinic

   Recent facet related procedure. Intraarticular corticosteroid in last 6-months. Age < 18 years; Current opioid use of greater than 100 oral morphine ...

10. Efineptakin alfa (NT-I7) Plus Pembrolizumab for the Treatment of Recurrent Glioblastoma - Mayo Clinic

    ... corticosteroids, or immunosuppressive drugs) =\< 2 years prior to ... corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) ...